“…An increase in the size of the sample will provide results that are easier to distinguish in terms of the effect that the ACE-2 gene has on COVID-19. The molecular approach was used to diagnose many pathogens, including : Proteus vulgaris, 31,32 Clostridium perfringens, 33 Staphylococcus auras, 34,35,36 Brucella melitensis, 37 Pseudomonas spp, 38 Toxoplasma spp 39,40 and SARS-Cov-2. 41,42 Also, Chronic Myeloid Leukemia, 43 Adenocarcinoma, 44,45 and another cancers 46 ,were considered severe genetic illnesses and diagnostic by PCR was suggested.…”